Is Cencora Stock Underperforming the Dow? Despite lagging behind the Dow over the past 12 months, Cencora continues to receive a highly bullish outlook from Wall Street analysts. Barchart · Sep 9
Is Wall Street Bullish or Bearish on Cencora Stock? Cencora has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects. Barchart · Aug 12
Cencora Earnings Preview: What to Expect Cencora is scheduled to release its third-quarter results next month, with analysts projecting single-digit earnings growth. Barchart · Jul 17
Are Wall Street Analysts Bullish on Cencora Stock? Cencora has consistently outperformed the broader market over the past year, and analysts are maintaining a strongly bullish outlook on the company’s growth and earnings potential. Barchart · May 14
What You Need to Know Ahead of Cencora's Earnings Release Cencora is scheduled to report its second-quarter results next month, and analysts project a single-digit increase in earnings. Barchart · Apr 17
Is Cencora Stock Outperforming the S&P 500? Due to Cencora's outperformance relative to the broader S&P 500 Index, Wall Street analysts remain strongly optimistic about the stock’s outlook. Barchart · Mar 6
What to Expect From Cencora's Next Quarterly Earnings Report Cencora is set to report its first-quarter earnings next month, and analysts are anticipating a single-digit increase in its bottom line. Barchart · Jan 9
How Is Cencora’s Stock Performance Compared to Other Medical Stocks? While Cencora’s recent performance has lagged behind other healthcare stocks, analysts express strong confidence in its long-term growth potential. Barchart · Dec 3, 2025
3 Stocks at Fresh 52-Week AND Record Highs to Buy Now Both the NYSE and Nasdaq had more stocks hitting new 52-week highs than lows yesterday. Among the many choices were three stocks also hitting all-time highs. All three have the potential to maintain momentum in the near and long term. Barchart · Nov 26, 2025
Cencora Stock: Is Wall Street Bullish or Bearish? Pharma distributor Cencora has continued to outpace the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects. Barchart · Nov 11, 2025
What to Expect From Cencora's Q4 2025 Earnings Report Cencora is scheduled to release its fourth-quarter results next month, with analysts projecting double-digit earnings growth. Barchart · Oct 22, 2025
Cencora Stock: Is COR Outperforming the Health Care Sector? Cencora has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects. Barchart · Sep 15, 2025
Cencora Stock: Analyst Estimates & Ratings Cencora has outpaced the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects. Barchart · Aug 13, 2025
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion. Benzinga · Aug 6, 2025
Barchart · Jul 8, 2025 Here's What to Expect From Cencora's Next Earnings Report Cencora is scheduled to release its second-quarter results next month, with analysts projecting double-digit earnings growth.
Barchart · Jun 10, 2025 Is Cencora Stock Outperforming the Dow? Due to Cencora’s strong performance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.
Barchart · May 14, 2025 Do Wall Street Analysts Like Cencora Stock? Cencora has significantly outperformed the broader market over the past year, and analysts remain strongly bullish on the stock’s prospects.
Barchart · Apr 25, 2025 Earnings Preview: What To Expect From Cencora's Report Cencora is scheduled to report its second-quarter results next month, with analysts projecting a single-digit earnings growth.
MarketBeat · Apr 9, 2025 Top 3 S&P 500 Winners in a Losing Market Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.
Barchart · Apr 4, 2025 This ‘Recession-Proof’ Stock Just Set New Highs and Is Flashing ‘Buy’ Signals Drug stocks like Cencora tend to be recession-proof, making today’s Chart of the Day especially relevant following a tariffs-driven selloff.
Barchart · Mar 12, 2025 Is Cencora Stock Outperforming the Nasdaq? As Cencora has outperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Barchart · Feb 13, 2025 Cencora Stock Outlook: Is Wall Street Bullish or Bearish? Despite Cencora's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's future.
Barchart · Jan 8, 2025 Cencora's Quarterly Earnings Preview: What You Need to Know As Cencora prepares to release its first-quarter earnings this month, analysts project a modest single-digit bottom-line surge.
Barchart · Dec 22, 2024 Is Cencora Stock Underperforming the S&P 500? Cencora has trailed the S&P 500 index over the past year, but analysts remain highly bullish about the stock’s prospects.
Barchart · Nov 19, 2024 Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink? Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.